The genetics of familial hypercholesterolemia and emerging therapies

Item

http://www.wikidata.org/entity/Q35043485

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The genetics of familial hypercholesterolemia and emerging therapies

@en

type

Item

label

The genetics of familial hypercholesterolemia and emerging therapies

@en

prefLabel

The genetics of familial hypercholesterolemia and emerging therapies

@en

P1476

The genetics of familial hypercholesterolemia and emerging therapies

@en

P2093

Anja Vogt

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for children with familial hypercholesterolemia

Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol

Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity

Lipoprotein(a) as a cardiovascular risk factor: current status

New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

P304

27-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TACG.S44315

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272191212

http://www.w3.org/2001/XMLSchema#string

P698

25670911

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

4315461

http://www.w3.org/2001/XMLSchema#string